Reuters logo
BRIEF-IntelGenx submits Montelukast VersaFilm(tm) clinical trial application with Health Canada
2017年11月9日 / 晚上10点03分 / 13 天前

BRIEF-IntelGenx submits Montelukast VersaFilm(tm) clinical trial application with Health Canada

Nov 9 (Reuters) - IntelGenx Technologies Corp

* IntelGenx submits Montelukast VersaFilm(tm) clinical trial application with Health Canada

* IntelGenx - ‍submitted CTA to Health Canada for approval to initiate its Phase 2a POC study with Montelukast in mild to moderate alzheimer’s disease​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below